Personalized T-cell therapy eliminates detectable metastatic kidney tumor in adolescent after multiple relapses

Researchers and physicians at the Hopp Children's Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment success in an adolescent with an advanced, therapy-resistant kidney tumor.

Researchers and physicians at the Hopp Children's Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment outcome in an adolescent with an advanced, treatment-resistant kidney tumor. Using a novel, personalized T-cell therapy, they…